{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:32:08Z","timestamp":1777725128949,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["19K19372"],"award-info":[{"award-number":["19K19372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10689-024-00390-3","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T14:01:38Z","timestamp":1715436098000},"page":"393-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review"],"prefix":"10.1007","volume":"23","author":[{"given":"Hiroyuki","family":"Matsubayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Kiyozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Higashigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ishiwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teichi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Uesaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"390_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.semdp.2014.08.003","volume":"31","author":"LD Wood","year":"2014","unstructured":"Wood LD, Klimstra DS (2014) Pathology and genetics of pancreatic neoplasms with acinar differentiation. Semin Diagn Pathol 31:491\u2013497","journal-title":"Semin Diagn Pathol"},{"key":"390_CR2","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.3748\/wjg.v28.i40.5827","volume":"28","author":"LF Calimano-Ramirez","year":"2022","unstructured":"Calimano-Ramirez LF, Daoud T, Gopireddy DR et al (2022) Pancreatic acinar cell carcinoma: a comprehensive review. World J Gastroenterol 28:5827\u20135844","journal-title":"World J Gastroenterol"},{"key":"390_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s10038-022-01097-y","volume":"68","author":"H Matsubayashi","year":"2023","unstructured":"Matsubayashi H, Todaka A, Kawakami T et al (2023) Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. J Hum Genet 68:81\u201386","journal-title":"J Hum Genet"},{"key":"390_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103033","volume":"60","author":"K Mizukami","year":"2020","unstructured":"Mizukami K, Iwasaki Y, Kawakami E et al (2020) Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine 60:103033","journal-title":"EBioMedicine"},{"key":"390_CR5","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1038\/srep08829","volume":"5","author":"T Furukawa","year":"2015","unstructured":"Furukawa T, Sakamoto H, Takeuchi S et al (2015) Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas. Sci Rep 5:8829","journal-title":"Sci Rep"},{"key":"390_CR6","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.3748\/wjg.v28.i45.6421","volume":"28","author":"CL Lee","year":"2022","unstructured":"Lee CL, Holter S, Borgida A et al (2022) Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: a case report and review of literature. World J Gastroenterol 28:6421\u20136432","journal-title":"World J Gastroenterol"},{"key":"390_CR7","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1200\/JCO.23.00561","volume":"41","author":"D Mandelker","year":"2023","unstructured":"Mandelker D, Marra A, Zheng-Lin B et al (2023) Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma. J Clin Oncol 41:5151\u20135162","journal-title":"J Clin Oncol"},{"key":"390_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6718","volume":"10","author":"M Lelong","year":"2022","unstructured":"Lelong M, Raoul JL, Touchefeu Y et al (2022) Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis. Clin Case Rep 10:e6718","journal-title":"Clin Case Rep"},{"key":"390_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013113","volume":"97","author":"M Li","year":"2018","unstructured":"Li M, Mou Y, Hou S et al (2018) Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: a case report. Medicine (Baltimore) 97:e13113","journal-title":"Medicine (Baltimore)"},{"key":"390_CR10","doi-asserted-by":"publisher","first-page":"117955492210901","DOI":"10.1177\/11795549221090186","volume":"16","author":"JY Xu","year":"2022","unstructured":"Xu JY, Guan WL, Lu SX et al (2022) Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature. Clin Med Insights Oncol 16:11795549221090186","journal-title":"Clin Med Insights Oncol"},{"key":"390_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MPA.0000000000001718","volume":"50","author":"H Takahashi","year":"2021","unstructured":"Takahashi H, Ikeda M, Shiba S et al (2021) Multicenter retrospective analysis of chemotherapy for advanced pancreatic acinar cell carcinoma: potential efficacy of platinum- and irinotecan-containing regimens. Pancreas 50:77\u201382","journal-title":"Pancreas"},{"key":"390_CR12","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u201347","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377:523\u2013533","journal-title":"N Engl J Med"},{"key":"390_CR14","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","volume":"375","author":"MR Mirza","year":"2016","unstructured":"Mirza MR, Monk BJ, Herrstedt J et al (2016) Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med 375:2154\u20132164","journal-title":"N Engl J Med"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M et al (2019) Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 381:317\u2013327","journal-title":"N Engl J Med"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1097\/MPA.0000000000002150","volume":"51","author":"T Sunami","year":"2022","unstructured":"Sunami T, Yamada A, Kondo T et al (2022) Exceptional response of pancreatic acinar cell carcinoma and bile duct cancer to platinum-based chemotherapy in a family with a germline BRCA2 variant. Pancreas 51:1258\u20131262","journal-title":"Pancreas"},{"key":"390_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","volume":"28","author":"T Okusaka","year":"2023","unstructured":"Okusaka T, Nakamura M, Yoshida M et al (2023) Clinical practice guidelines for pancreatic cancer 2022 from the japan pancreas society: a synopsis. Int J Clin Oncol 28:493\u2013511","journal-title":"Int J Clin Oncol"},{"issue":"2119\u20132132","key":"390_CR18","volume":"160","author":"T Golan","year":"2021","unstructured":"Golan T, O\u2019Kane GM, Denroche RE et al (2021) Genomic features and classification of homologous recombination deficient pancreatic ductal adenocarcinoma. Gastroenterology 160(2119\u20132132):e9","journal-title":"Gastroenterology"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-22-3724","volume":"29","author":"V Florou","year":"2023","unstructured":"Florou V, Elliott A, Bailey MH et al (2023) Comparative genomic analysis of pancreatic acinar cell carcinoma (PACC) and pancreatic ductal adenocarcinoma (PDAC) unveils new actionable genomic aberrations in PACC. Clin Cancer Res 29:3408\u20133417","journal-title":"Clin Cancer Res"},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000515267","volume":"37","author":"L Dreikhausen","year":"2021","unstructured":"Dreikhausen L, Schulte N, Belle S et al (2021) Pancreatic acinar cell carcinoma with germline BRCA2 mutation and severe pancreatic panniculitis: a case report. Visc Med 37:447\u2013450","journal-title":"Visc Med"},{"key":"390_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","volume":"78","author":"Y Okawa","year":"2023","unstructured":"Okawa Y, Iwasaki Y, Johnson TA et al (2023) Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. J Hepatol 78:333\u2013342","journal-title":"J Hepatol"},{"key":"390_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s10038-023-01153-1","volume":"68","author":"A Ueki","year":"2023","unstructured":"Ueki A, Yoshida R, Kosaka T et al (2023) Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1\/2 variant carriers in Japan. J Hum Genet 68:517\u2013526","journal-title":"J Hum Genet"},{"key":"390_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","volume":"8","author":"Y Momozawa","year":"2022","unstructured":"Momozawa Y, Sasai R, Usui Y et al (2022) Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol 8:871\u2013878","journal-title":"JAMA Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-024-00390-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T06:13:58Z","timestamp":1721196838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-024-00390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s10689-024-00390-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A written informed consent for the publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}